-
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
Study
EGAS00001001805
-
Clonal selection and double hit events involving tumor suppressor genes underlie relapse from total therapy
Study
EGAS00001001810
-
WGS of 32 paired SRCC samples
Study
EGAS00001002668
-
Multiomics Characterization of Low-grade Serous Ovarian Carcinoma
Study
EGAS00001004724
-
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma
Study
EGAS00001004753
-
H3K27ac and RNA-seq data of neuroblastoma PDXs and/or primary tumors
Study
EGAS00001002505
-
Subtype specific progression from DCIS to invasive breast cancer
Study
EGAS00001001866
-
Multi-omics analysis of primary glioblastoma cell-lines shows recapitulation of pivotal molecular features of parental tumors
Study
EGAS00001001871
-
Pediatric Papillary Thyroid Carcinoma RNA-Seq
Study
EGAS00001005182
-
Pediatric Papillary Thyroid Carcinoma Whole Exome Sequencing
Study
EGAS00001005187
-
Non-Mendalian inheritance of extrachromosal DNA elements can drive disease evolution in glioblastoma
Study
EGAS00001001878
-
EATL-II STUDY
Study
EGAS00001001879
-
Analysis of Multiparametric MR imaging and tumor tissue sampling to identify response and acquired resistance to HIF-2 inhibition in patients with advanced clear cell renal cell carcinoma enrolled in a phase 1, multiple-dose, dose-escalation trial of PT2385, a HIF-2alpha inhibitor
Study
EGAS00001003506
-
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma - 30 whole exomes
Study
EGAS00001001892
-
Integrated genetic and epigenetic analysis of myxofibrosarcoma
Study
EGAS00001002889
-
A MITF germline mutation predisposes to melanoma and renal cell carcinoma
Study
EGAS00000000048
-
PUMCH-ICT Hepatocellular Carcinoma Study Data Access Committee
Dac
EGAC00001000070